Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit.
Bumma N, Nagasaka M, Hemingway G, Miyashita H, Chowdhury T, Kim S, Vankayala HM, Ahmed S, Jasti P. Bumma N, et al. Clin Lymphoma Myeloma Leuk. 2020 May;20(5):305-311. doi: 10.1016/j.clml.2019.11.014. Epub 2019 Dec 28. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32144026 Clinical Trial.
Multidisciplinary amyloidosis care in the era of personalized medicine.
Bumma N, Kahwash R, Parikh SV, Isfort M, Freimer M, Vallakati A, Redder E, Campbell CM, Sharma N, Efebera Y, Stino A. Bumma N, et al. Front Neurol. 2022 Oct 13;13:935936. doi: 10.3389/fneur.2022.935936. eCollection 2022. Front Neurol. 2022. PMID: 36341129 Free PMC article. Review.
[No title available]
[No authors listed] [No authors listed] PMID: 36164142
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Khan AM, Yucebay F, Zhao Q, Umyarova E, Cottini F, Bumma N, Rosko A, Benson D, Sharma N, Efebera Y, Devarakonda S. Khan AM, et al. Among authors: bumma n. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):e85-e96. doi: 10.1016/j.clml.2022.10.004. Epub 2022 Oct 27. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36411211
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.
Khan AM, Ozga M, Bhatt H, Faisal MS, Ansari S, Zhao Q, Bumma N, Cottini F, Devarakonda S, Rosko A, Sharma N, Umyarova E, Benson D. Khan AM, et al. Among authors: bumma n. Clin Lymphoma Myeloma Leuk. 2023 Mar;23(3):e182-e189. doi: 10.1016/j.clml.2022.12.001. Epub 2022 Dec 5. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36581554
Daratumumab proves safe and highly effective in AL amyloidosis.
Khouri J, Kin A, Thapa B, Reu FJ, Bumma N, Samaras CJ, Liu HD, Karam MA, Reed J, Mathur S, Faiman BM, Devries G, Zonder J, Valent J. Khouri J, et al. Among authors: bumma n. Br J Haematol. 2019 Apr;185(2):342-344. doi: 10.1111/bjh.15455. Epub 2018 Jun 25. Br J Haematol. 2019. PMID: 29938774 Free article. No abstract available.
Potential of NK cells in multiple Myeloma therapy.
Khan AM, Devarakonda S, Bumma N, Chaudhry M, Benson DM Jr. Khan AM, et al. Among authors: bumma n. Expert Rev Hematol. 2019 Jun;12(6):425-435. doi: 10.1080/17474086.2019.1617128. Epub 2019 May 22. Expert Rev Hematol. 2019. PMID: 31070067
42 results